Uveitis Fellowship

What Is a Uveitis Fellowship?

Uveitis fellowship is a one-year subspecialty training program completed after ophthalmology residency. It focuses on the diagnosis and management of intraocular inflammation—a category broad enough to encompass anterior uveitis, intermediate uveitis, posterior uveitis, panuveitis, scleritis, and related ocular inflammatory conditions. The unifying thread is not anatomy but mechanism: immune-mediated, infectious, or masquerade processes that threaten vision through inflammation rather than degeneration or structural failure.

The subspecialty sits at a genuine intersection of ophthalmology, rheumatology, and infectious disease. A uveitis specialist must be fluent in ocular anatomy and examination, but also in immunology, systemic autoimmune disease, and the pharmacology of immunosuppression. That dual competency is rare in either parent specialty and is precisely what makes the training valuable—and the clinical role distinct.

Programs are accredited through the ACGME and are listed through the Association of University Professors of Ophthalmology (AUPO). The fellowship landscape is concentrated in academic medical centers; pure uveitis fellowships in community or private settings are uncommon. One year is the standard duration, though a small number of programs offer optional research extensions.

What Do Uveitis Specialists Actually Do All Day?

The dominant mode is outpatient clinic. A typical day centers on slit-lamp examination of patients with active or quiescent intraocular inflammation, assessment of treatment response, adjustment of immunosuppressive regimens, and investigation of new or evolving diagnoses. The pace is deliberate rather than rapid—visits are longer than in general ophthalmology because the history, review of systems, lab results, and imaging interpretation demand it.

A workup for a patient with new posterior uveitis might involve fluorescein angiography, indocyanine green angiography, optical coherence tomography, chest imaging, serologic panels for syphilis, tuberculosis, and sarcoidosis, and a coordinated conversation with rheumatology or infectious disease. You are not ordering tests reflexively; you are constructing and narrowing a differential in real time.

Procedures exist but are not the core activity. Intravitreal injections—corticosteroids most commonly—are performed regularly. Sub-Tenon and periocular injections for posterior segment disease are part of the toolkit. Implantation of sustained-release intravitreal devices occurs at programs with sufficient surgical volume. You will not be doing vitrectomies as a primary surgeon; that is retina's domain, though you will co-manage patients who require surgical intervention for complications of inflammation.

Systemic immunosuppression management is a defining feature that separates uveitis from every other ophthalmic subspecialty. Initiating methotrexate, mycophenolate, azathioprine, or biologic agents—and monitoring patients for toxicity—is standard practice. At many programs, the uveitis attending is the prescribing physician for these agents, not merely the referring one. This is unusual for an ophthalmologist and requires a comfort level with systemic medicine that most ophthalmic training does not develop.

A portion of the work involves co-management of complex cases: a patient with JIA-associated uveitis whose disease flares when the rheumatologist adjusts the systemic regimen; a patient with sarcoidosis whose pulmonary disease and ocular disease diverge in their treatment needs; a patient with syphilitic uveitis whose HIV status changes the treatment algorithm. These are not consultations that resolve in one visit. They are longitudinal relationships, often spanning years or decades.

The Patient Population You Will Serve

Uveitis patients are not a homogeneous group, and that heterogeneity is both the intellectual draw and the emotional weight of the subspecialty.

HLA-B27–associated disease—ankylosing spondylitis, reactive arthritis, inflammatory bowel disease—generates a large share of referrals, particularly for anterior uveitis. These patients are often young, often male, and often have recurrent disease that flares unpredictably. They frequently have an established rheumatology relationship; your role is to manage the ocular manifestation in concert with systemic therapy.

Sarcoidosis produces a wide spectrum of ocular inflammation, from anterior granulomatous uveitis to multifocal choroiditis to optic nerve involvement. The diagnostic challenge is real—biopsy-confirmed sarcoidosis is not always obtainable, and clinical diagnosis requires integrating imaging, serology, and response to treatment.

JIA-associated uveitis is a pediatric population that warrants separate mention. The inflammation is characteristically anterior, chronic, and asymptomatic in early stages—children do not complain of pain or redness, and the diagnosis is often made on screening examination. The stakes are high: band keratopathy, cataract, and glaucoma accumulate silently if inflammation is inadequately controlled. Managing a child with JIA-associated uveitis means managing the family as well as the patient, and coordinating closely with pediatric rheumatology over years.

Infectious uveitis—toxoplasma retinochoroiditis, ocular tuberculosis, syphilitic uveitis, acute retinal necrosis from herpes viruses—requires a different diagnostic posture. Missing an infectious etiology and treating empirically with corticosteroids or immunosuppression can accelerate catastrophic vision loss. The clinical imperative to rule out infection before suppressing immunity is not hypothetical; it is a recurring, high-stakes decision point.

Rare autoimmune syndromes—Vogt-Koyanagi-Harada disease, sympathetic ophthalmia, birdshot chorioretinopathy, serpiginous choroiditis—are seen in referral-heavy uveitis practices at a frequency that exceeds anything in general ophthalmology. These are the cases that appear in the literature and drive the research agenda. They are also the cases that are most diagnostically challenging and most emotionally demanding, because the prognosis for vision is often uncertain and the treatment carries meaningful systemic risk.

Across all categories, chronicity is the norm. You will know these patients. You will watch some of them lose vision despite optimal treatment, and you will watch others maintain function for decades. The longitudinal relationship is not incidental to the work—it is the work.

Core Procedural and Diagnostic Skills You Will Build

Fellowship will advance your slit-lamp examination to a level of precision that general residency training does not require. Grading anterior chamber and vitreous cell and flare by standardized criteria—using the SUN Working Group classification system—is foundational. Consistency in grading matters because treatment decisions are tied to cell count trajectories, and inter-visit variability undermines clinical reasoning.

Multimodal imaging interpretation is central. Fluorescein angiography and indocyanine green angiography are used to characterize choroidal and retinal vascular involvement, identify areas of active inflammation, and monitor treatment response. OCT—both spectral domain and enhanced depth imaging—is used to evaluate cystoid macular edema, subretinal fluid, choroidal thickness, and structural damage from chronic inflammation. You will read these studies yourself rather than depending on a separate reading service.

Procedural competencies include intravitreal corticosteroid injection (triamcinolone acetonide, dexamethasone implant), sub-Tenon injection, and anterior chamber paracentesis for diagnostic purposes—PCR of aqueous humor for viral or bacterial nucleic acids is a standard diagnostic tool in the right clinical context. At programs with surgical uveitis volume, you may assist with or perform implantation of sustained-release fluocinolone acetonide devices.

Systemic pharmacology is a skill set in its own right. Initiating and titrating methotrexate, mycophenolate mofetil, azathioprine, cyclosporine, tacrolimus, and biologic agents including TNF-alpha inhibitors and IL-6 inhibitors requires knowledge of dosing, contraindications, drug interactions, and monitoring protocols. Ordering and interpreting baseline and surveillance labs—CBC, LFTs, renal function, TB testing before biologics—is expected practice. This is not borrowed from rheumatology; it is something you own.

How Uveitis Sits Within the Ophthalmology Ecosystem

Most ophthalmic subspecialties operate largely within the eye. Retina specialists manage retinal degeneration and vascular disease; cornea specialists manage the ocular surface; glaucoma specialists manage intraocular pressure and optic nerve. The systemic medicine interface exists in all of them, but it is usually upstream—other physicians manage the systemic disease, and the ophthalmologist manages the ocular consequence.

Uveitis inverts this relationship in a meaningful way. The uveitis specialist is often the physician who suspects, works up, and in some cases diagnoses the underlying systemic disease. A patient presenting with granulomatous panuveitis may not yet have a sarcoidosis diagnosis. A patient with bilateral intermediate uveitis may not yet have had a workup for multiple sclerosis or sarcoid. You are not waiting for a referral from medicine—you are generating the referral in the other direction, or managing the systemic treatment yourself.

This creates a practice pattern that looks more like an internist-subspecialist hybrid than a surgical subspecialist. Your referral relationships are with rheumatology, infectious disease, pulmonology, and pediatric rheumatology as much as with other ophthalmologists. In academic centers, joint uveitis-rheumatology clinics exist at some institutions, and the collaborative model is explicit.

The scope overlap with retina is real and worth naming. Posterior uveitis affects the retina and choroid, and some retina specialists manage inflammatory conditions—particularly in community settings where no uveitis specialist is available. At academic centers, delineation is clearer: uveitis manages the inflammatory disease, retina manages the structural complications. But in practice, patients with complex posterior uveitis often have both specialists involved, and collegial communication is not optional.

Neuro-ophthalmology shares some patient overlap—optic neuritis in the context of uveitis, MS-associated intermediate uveitis, and orbital inflammatory disease are areas where both subspecialties may be consulted. The boundary is usually clear but occasionally contested.

Personality and Cognitive Traits That Thrive Here

The practitioners who report the highest satisfaction in uveitis share a cluster of traits that are worth examining honestly before you commit to the path.

Comfort with diagnostic uncertainty. Many uveitis cases never receive a definitive etiologic diagnosis. You treat the inflammation, monitor the response, and revise your working diagnosis as new information emerges. This is not a failure of clinical reasoning—it is the nature of the disease. Physicians who need a clean answer before acting will find this chronically uncomfortable.

Genuine interest in systemic medicine and immunology. If the immunopathology of granulomatous disease, the mechanism of TNF-alpha blockade, or the interaction between HLA haplotype and disease phenotype strikes you as interesting rather than obligatory, that is a meaningful signal. The intellectual content of uveitis is immunologic at its core. Physicians who entered ophthalmology specifically to minimize internal medicine will find the content of this subspecialty misaligned with that preference.

Patience for complex chronic disease management. Uveitis patients return. The relationship extends over years, and the trajectory is not always upward. You will have patients who plateau, patients who lose ground slowly, and patients who experience acute exacerbations that require rapid adjustment. The satisfaction in this work comes from knowing a patient well enough to recognize a subtle change—not from the procedural rhythm of a high-volume surgical day.

Detective-style differential diagnosis. The workup for uveitis is a structured elimination of a broad differential, and the process is genuinely detective-like. Finding an unexpected syphilis result, recognizing a constellation of findings that points to birdshot chorioretinopathy, or suspecting masquerade syndrome in a case initially attributed to inflammation—these moments are intellectually satisfying in a specific way that not every clinician responds to equally.

Tolerance for emotionally heavy cases. Some uveitis patients lose vision. Some are young. Some are children. Managing the clinical relationship with a patient whose disease is not responding, who has developed drug toxicity, or who is facing legal blindness requires emotional capacity that is not optional in this subspecialty. This is not unique to uveitis, but the chronicity of the relationship intensifies it.

Traits and Preferences That May Signal Poor Fit

These are not disqualifying character flaws. They are genuine preferences that predict dissatisfaction in this specific practice environment. Naming them directly is more useful than allowing a mismatch to develop after fellowship.

Strong preference for procedural volume. If the most satisfying clinical days are ones with high surgical throughput—cases completed, structures fixed, results visible—uveitis will likely feel slow and incomplete. The procedural component is real but modest. You will not build a practice around surgical volume.

Discomfort with systemic medication management. Initiating immunosuppression carries risk—opportunistic infection, hepatotoxicity, teratogenicity, malignancy risk over time. Managing that risk requires comfort with pharmacology and with communicating uncertainty to patients. Physicians who prefer to limit their scope to the eye and refer systemic management elsewhere will find that approach inadequate in uveitis practice.

Desire for broader surgical scope. Uveitis fellowship does not produce surgeons. If you entered ophthalmology residency energized by the operating room—vitreoretinal surgery, corneal transplantation, complex anterior segment work—uveitis fellowship moves away from that, not toward it. The training you receive will not position you for a surgical subspecialty career.

Low tolerance for ambiguity and treatment failure. Uveitis has conditions with no reliable treatment, cases that respond partially but not completely, and outcomes that are simply worse than the patient or physician hoped. The evidence base for many treatment decisions is weaker than in higher-prevalence diseases. If treatment failure feels like personal failure, or if ambiguous evidence is uncomfortable to act on, the day-to-day reality of uveitis practice will be difficult to sustain.

Lifestyle, Schedule, and Practice Reality

Uveitis is among the more outpatient-dominant ophthalmic subspecialties. The typical practice involves scheduled clinic days, multimodal imaging interpretation, and periodic procedures—intravitreal or periocular injections—that are performed in clinic or a minor procedure suite rather than a dedicated operating room block. Emergency call exists but is less burdensome than in retina or cornea; acute vision-threatening uveitis is urgent but rarely requires emergent surgical intervention in the middle of the night.

Academic practice is the predominant model. The number of uveitis specialists in pure private practice is small relative to retina or cornea, and uveitis-only practices outside of academic medical centers are uncommon. The more typical community scenario is an ophthalmologist with uveitis fellowship training who serves as the regional referral point and manages uveitis within a broader general or comprehensive ophthalmology practice.

Geographic concentration is real. Fellowship-trained uveitis specialists cluster at academic centers in major metropolitan areas. Physicians seeking to practice in underserved or rural settings after uveitis fellowship should anticipate that the referral volume to support a uveitis-focused practice may not exist, and should plan for a comprehensive scope of practice.

Compensation in uveitis generally trails the procedurally intensive ophthalmic subspecialties—retina in particular. The outpatient, longitudinal, medical-management-heavy practice model does not generate the relative value unit volume that surgical subspecialties produce. This is a structural reality of how physician compensation is calculated in US medicine, not a judgment about the value of the work. Candidates should research current compensation benchmarks through sources such as the MGMA or AAO practice surveys and approach the decision with accurate expectations. See the PGY Zero data pages for current reference points.

How Competitive Is the Uveitis Fellowship Match?

The uveitis fellowship landscape is small. Approximately thirty programs in the United States offer dedicated uveitis fellowship positions, with most programs accepting one fellow per year. The absolute number of positions available in any application cycle is limited, which creates meaningful competitiveness—though the applicant pool is also smaller than in retina or corneal surgery.

Research productivity is weighted heavily. Program directors in uveitis training are typically academic physicians with active research programs, and they seek fellows who can contribute to and extend that work. At minimum, demonstrated engagement with the literature—a case report, a poster presentation, a research elective in an immunology-adjacent lab—signals genuine interest. Publications in peer-reviewed journals, particularly those with a uveitis or ocular immunology focus, are competitive differentiators.

Letters of recommendation from physicians with uveitis or ocular immunology connections carry disproportionate weight. A letter from a fellowship director or known figure in the uveitis community—however small that community is—signals that the applicant has already engaged with the subspecialty at a meaningful level. Letters from general ophthalmology or retina attendings who do not know the uveitis world are less informative to program directors.

Applying broadly is standard practice and should be the default assumption rather than a fallback. With approximately thirty programs, applying to all or most of them is logistically feasible and strategically rational. Candidates who narrow to a handful of geographic preferences without strong existing connections to those programs accept meaningful risk.

Away rotations, where available, function both as genuine auditions and as relationship-building opportunities. Cold-emailing fellowship directors to request a rotation during residency is a normal and accepted practice in this subspecialty; the community is small enough that directors often remember applicants they have met in clinic.

Building a Competitive Application During Residency

The candidates who match at strong programs typically began building their application in PGY-1 or PGY-2, not PGY-4. Early exposure is not about résumé padding—it is about confirming fit and developing genuine content to discuss in interviews and personal statements.

Seek out your program's uveitis attending early in residency. Volunteer for complex cases, ask to be included on interesting workups, and express interest in research collaboration. If your program does not have a dedicated uveitis specialist, identify the nearest academic center that does and inquire about visiting rotations.

Research engagement does not require a fully independent project. A case report on an unusual presentation, a retrospective chart review of a clinical question, or a systematic review in an area of genuine uncertainty are achievable within residency constraints and demonstrate the kind of scholarly engagement program directors look for. Presenting at a regional ophthalmology meeting or submitting an abstract to ARVO or the AAO uveitis section provides additional evidence of commitment.

Attending meetings—particularly the annual meeting of the American Uveitis Society, held in conjunction with AAO—serves multiple purposes simultaneously. You will hear the current research agenda, identify faculty whose work interests you, and begin introducing yourself to a small enough community that faces are remembered. Residency travel funds sometimes support this; if not, the investment is worth considering independently.

Joining the American Uveitis Society as a resident member is a concrete step that costs little and signals orientation toward the field. Reviewing fellowship program listings through AUPO allows you to identify programs with research emphases that align with your interests, which is the foundation of a coherent application narrative.

How Uveitis Fellowship Compares to Other Ophtho Subspecialties

A structured comparison helps applicants self-sort without requiring exhaustive research into every subspecialty.

Uveitis versus Retina: Retina is the highest-volume surgical subspecialty in ophthalmology. Fellows perform vitreoretinal surgery—vitrectomy, membrane peeling, retinal detachment repair—in substantial numbers. The practice model supports both academic and high-volume private practice. Systemic medicine involvement is limited. Patient relationships are often episodic rather than continuous. Compensation is among the highest in ophthalmology. If surgical volume and procedural breadth drive your satisfaction, retina is the stronger fit. If systemic medicine and diagnostic complexity are the draw, uveitis diverges sharply from retina despite sharing some posterior segment patients.

Uveitis versus Cornea/External Disease: Cornea fellowship combines anterior segment surgery—keratoplasty, DSAEK, DMEK, refractive surgery—with management of ocular surface disease, some of which is immune-mediated (cicatricial pemphigoid, Stevens-Johnson syndrome, graft rejection). The surgical volume in cornea is meaningful. Systemic medicine overlap exists but is narrower than in uveitis. Private practice is viable. If anterior segment surgery appeals more than posterior segment inflammatory disease, cornea is the natural comparison point.

Uveitis versus Neuro-Ophthalmology: Neuro-ophthalmology shares uveitis's emphasis on diagnosis, systemic disease, and longitudinal relationships. The procedural volume in neuro-ophthalmology is low. The intellectual model—constructing a neuroanatomic diagnosis from clinical findings—is similarly detective-oriented. Systemic medicine overlap includes MS, myasthenia gravis, giant cell arteritis, and intracranial pathology. Both subspecialties are academically concentrated and compensation trails surgical subspecialties. Candidates drawn to uveitis for its diagnostic complexity and systemic medicine interface may find neuro-ophthalmology worth comparing directly.

Uveitis versus Glaucoma: Glaucoma involves a significant surgical component—trabeculectomy, tube shunts, laser procedures, minimally invasive glaucoma surgery—as well as longitudinal medical management. Systemic medicine involvement is limited. Private practice is highly viable. The patient relationship is chronic but the clinical visits are more structured and the decision points more algorithmic than in uveitis. Glaucoma and uveitis intersect in patients with inflammatory glaucoma, which is a real but narrow overlap.

Questions to Ask Yourself Before Committing

These questions are not a checklist with correct answers. They are intended to surface genuine preferences that predict fit, not to filter for a particular type of person.

Next Steps If Uveitis Feels Like the Right Fit

If this page has increased rather than decreased your interest, the following actions are concrete and sequenced.